Malcolm Lloyd-Smith's Net Worth

$20 Million

Estimate Recalculated Jul 18, 2024 04:15PM EST

Who is Malcolm Lloyd-Smith?

Malcolm Lloyd-Smith has an estimated net worth of $20 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, and CADENCE PHARMACEUTICALS INC.

SEC CIK

Malcolm Lloyd-Smith's CIK is 0001557146

Past Insider Trading and Trends

2021 was Malcolm Lloyd-Smith's most active year for acquiring shares with 10 total transactions. Malcolm Lloyd-Smith's most active month to acquire stocks was the month of January. 2021 was Malcolm Lloyd-Smith's most active year for disposing of shares, totalling 16 transactions. Malcolm Lloyd-Smith's most active month to dispose stocks was the month of January. 2020 saw Malcolm Lloyd-Smith paying a total of $1,728,146.81 for 73,385 shares, this is the most they've acquired in one year. In 2022 Malcolm Lloyd-Smith cashed out on 54,491 shares for a total of $3,698,134.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $136.68

Chief Integration Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.64%
-15.32K
$103.56
-$1,572,196.57
143.56K
Scheduled
Feb 6 - Feb 8
Form 4
-5.51%
-1.67K
$110.02
-$183,290.49
28.58K
Scheduled
Jan 31
Form 4
+42.58%
8.04K
$72.33
-$1,136,694.92
26.93K
Scheduled
Aug 12 - Aug 15
Form 4
-4.57%
-3.38K
$80.42
-$272,167.89
70.7K
Scheduled
Feb 7 - Feb 8
Form 4
—
0
—
—
0
Jan 31
Form 4
-51.40%
-16.71K
$93.80
-$1,567,335.95
15.8K
Scheduled
Jul 27
Form 4/A
—
0
—
—
0
Feb 8
Form 4
—
0
$77.97
-$142,742.55
32.51K
Scheduled
Feb 10
Form 4
-3.21%
-4.13K
$116.16
-$479,668.44
124.22K
Scheduled
Feb 5 - Feb 8
Form 4
—
0
$77.26
-$1,594,718.18
29K
Scheduled
Jan 25 - Jan 26
Form 4
-7.22%
-2.26K
$90.73
-$204,775.80
29K
Scheduled
Nov 12
Form 4
-7.72%
-2.26K
$118.86
-$268,277.40
26.97K
Scheduled
Aug 5
Form 4
-7.20%
-1.93K
$99.45
-$192,329.14
24.94K
Scheduled
Apr 24
Form 4
-4.19%
-1.01K
$82.09
-$1,405,765.30
23.2K
Scheduled
Feb 7 - Feb 10
Form 4
-5.11%
-3.44K
$102.54
-$351,990.78
63.87K
Scheduled
Feb 5 - Feb 6
Form 4
—
0
$53.15
-$750,666.47
19.61K
Scheduled
Oct 14
Form 4
-4.56%
-920.00
$83.58
-$76,893.78
19.24K
Scheduled
Feb 6 - Feb 7
Form 4
-3.60%
-1.27K
$88.15
-$112,118.58
34.08K
Scheduled
Feb 5
Form 4
—
0
$62.73
-$851,045.76
15.32K
Scheduled
Nov 6 - Nov 7
Form 4
-7.20%
-2.27K
$82.84
-$188,241.31
29.3K
Scheduled
Feb 5 - Feb 6
Form 4
—
0
$46.49
-$1,122,425.05
13.02K
Scheduled
Jan 2
Form 4
—
0
$34.54
-$380,272.80
13.02K
Scheduled
May 18 - May 19
Form 4
-50.09%
-13.06K
$50.42
-$658,773.93
13.02K
Scheduled
Apr 12
Form 4
-43.79%
-843.00
$43.88
-$36,544.81
1.08K
Scheduled
Feb 6 - Feb 7
Form 4
—
0
$32.73
-$310,950.00
0
Scheduled
Sep 1
Form 4
—
0
$32.73
-$310,950.00
0
Scheduled
May 31
Form 4
—
0
—
—
0
Feb 5
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

CADENCE PHARMACEUTICALS INC No price found

SVP, Reg Affairs, Qual & Clin

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found